Flynn James E 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | Flynn James E | 1,125,083 2.590% | -1,035,917 (-47.94%) | Filing |
| 2021-02-12 12:29 pm Sale | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | Flynn James E | 2,161,000 5.010% | -208,166 (-8.79%) | Filing |
| 2020-10-26 5:08 pm Purchase | 2020-10-16 | 13G | Meridian Bioscience, Inc. VIVO | Flynn James E | 2,369,166 5.530% | 2,369,166 (New Position) | Filing |